TORONTO – Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine – called mRESVIA – to be available in early 2025. There are two other vaccines already available in Canada to protect seniors against severe

The post Health Canada approves Moderna’s mRNA RSV vaccine, company says appeared first on Medicine Hat News.